What is EVGN's gross margin?

Evogene (EVGN) has a gross margin of -2% and a net margin of -510%.

What is EVGN's P/E ratio?

Track Evogene (EVGN) P/E ratio, ROE, and valuation metrics over time.

Where can I see EVGN's full financials?

See Evogene (EVGN) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

Evogene (EVGN) Financials — Revenue, Earnings, Cash Flow

Also trades as: EVGN.TA (TLV) · $vol 0M

$0.42

-0.01 (-2.43%)

Weekly Expected Move ±12.3%

$0 $0 $0 $0 $1

NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 35 · $3.7M mcap · 9M float · 23.32% daily turnover · Short 25% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest

📊 Key Metrics

TTM

$1M

Revenue

-80.4% YoY

$-9M

Net Income

+36.3% YoY

$-12M

Free Cash Flow

+36.5% YoY

-2.3%

Gross Margin

-703.5%

Op. Margin

-509.5%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE265.3%

ROA-38.3%

ROIC101.3%

Valuation

P/E-0.4

P/B-1.5

EV/EBITDA0.2

Leverage

Debt/Equity-0.64

Current Ratio3.57

Interest Cov.-2.8x

Quality Scores

Piotroski F3/9

Altman Z-32.32

Beneish M-15.72